Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease

被引：0
作者：
Rawaha Ahmad
Andrey Postnov
Guy Bormans
Jan Versijpt
Mathieu Vandenbulcke
Koen Van Laere
机构：
[1] KU Leuven and University Hospitals Leuven,Department of Imaging & Pathology, Nuclear Medicine and Molecular Imaging
[2] University Hospital Leuven,Division of Nuclear Medicine
[3] National Research Nuclear University MEPhI,Laboratory for Radiopharmacy
[4] KU Leuven,Department of Neurology
[5] University Hospital Brussels,Old Age Psychiatry, Department of Psychiatry
[6] KU Leuven and University Hospitals Leuven,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2016年 / 43卷
关键词：
Cannabinoid type 2 receptor; CB; R; Neuroinflammation; PET imaging; Alzheimer’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2219 / 2227
页数：8
相关论文
共 50 条
[41]   Decreased serum angiogenin level in Alzheimer's disease [J].
Kim, Yong Nam ;
Kim, Do Hoon .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 38 (02) :116-120
[42]   The amygdala volume is decreased in patients with Alzheimer's disease [J].
Horínek, D ;
Hort, J ;
Brabec, J ;
Bojar, M ;
Krásensky, J ;
Seidl, Z ;
Petrovicky, P .
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2005, 68 (04) :235-240
[43]   Decreased plasma antioxidants in patients with Alzheimer's disease [J].
Kim, TS ;
Pae, CU ;
Yoon, SJ ;
Jang, WY ;
Lee, NJ ;
Kim, JJ ;
Lee, SJ ;
Lee, C ;
Paik, IH ;
Lee, CU .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (04) :344-348
[44]   Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine [J].
Aso, Ester ;
Andres-Benito, Pol ;
Carmona, Margarita ;
Maldonado, Rafael ;
Ferrer, Isidre .
JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (02) :489-500
[45]   Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway [J].
Wang, Lin ;
Liu, Bing-Jin ;
Cao, Yun ;
Xu, Wei-Qi ;
Sun, Dong-Sheng ;
Li, Meng-Zhu ;
Shi, Fang-Xiao ;
Li, Man ;
Tian, Qing ;
Wang, Jian-Zhi ;
Zhou, Xin-Wen .
MOLECULAR NEUROBIOLOGY, 2018, 55 (06) :4731-4744
[46]   Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway [J].
Lin Wang ;
Bing-Jin Liu ;
Yun Cao ;
Wei-Qi Xu ;
Dong-Sheng Sun ;
Meng-Zhu Li ;
Fang-Xiao Shi ;
Man Li ;
Qing Tian ;
Jian-Zhi Wang ;
Xin-Wen Zhou .
Molecular Neurobiology, 2018, 55 :4731-4744
[47]   Receptor tyrosine kinases (RTKs) consociate in regulatory clusters in Alzheimer's disease and type 2 diabetes [J].
Majumder, Piyali ;
Roy, Kasturi ;
Bagh, Sangram ;
Mukhopadhyay, Debashis .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 459 (1-2) :171-182
[48]   Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? [J].
Merighi, Stefania ;
Travagli, Alessia ;
Nigro, Manuela ;
Pasquini, Silvia ;
Cappello, Martina ;
Contri, Chiara ;
Varani, Katia ;
Vincenzi, Fabrizio ;
Borea, Pier Andrea ;
Gessi, Stefania .
BIOMOLECULES, 2023, 13 (06)
[49]   Receptor tyrosine kinases (RTKs) consociate in regulatory clusters in Alzheimer’s disease and type 2 diabetes [J].
Piyali Majumder ;
Kasturi Roy ;
Sangram Bagh ;
Debashis Mukhopadhyay .
Molecular and Cellular Biochemistry, 2019, 459 :171-182
[50]   P2X7 Receptor: an Emerging Target in Alzheimer’s Disease [J].
Qiang Huang ;
Jun Ying ;
Wen Yu ;
Yao Dong ;
Hao Xiong ;
Yiping Zhang ;
Jie Liu ;
Xifeng Wang ;
Fuzhou Hua .
Molecular Neurobiology, 2024, 61 :2866-2880
12345